BioSpace News Archive

Press Releases

Empowering the Immunocompromised and Elderly: ExeVir Bio presents promising XVR013m data at ID Week 2024

October 17, 2024
·
4 min read
Press Releases

Telix Q3 2024 Business Update – Quarterly Revenue Exceeds AU$200M

October 17, 2024
·
15 min read
Press Releases

MolecuLight’s Fluorescence Imaging: A Game-Changer for Bedside Biofilm Detection

October 17, 2024
·
2 min read
Press Releases

Avacta Expands its Pipeline with Two Novel Assets Developed Using its pre|CISION® Platform

October 17, 2024
·
4 min read
Press Releases

Ocugen to Host Conference Call on Friday, November 8 at 8:30 A.M. ET to Discuss Business Updates and Third Quarter 2024 Financial Results

October 17, 2024
·
2 min read
Press Releases

Theratechnologies Unveils Study Design and Baseline Characteristics of PROMISE-US Trial of Ibalizumab in Heavily Treatment-Experienced People with HIV and Multidrug Resistance

October 17, 2024
·
6 min read
Press Releases

Biodexa’s MX-110 Continues to Show Promise in Recurrent Glioblastoma (rGBM), the Deadliest Brain Cancer

October 17, 2024
·
6 min read
Press Releases

BioAegis Therapeutics Enrolls First Patient in Phase 2 Clinical Trial of Gelsolin, an Immune Regulator, for the Treatment of Acute Respiratory Distress Syndrome (ARDS)

October 17, 2024
·
4 min read
Press Releases

Bright Peak Therapeutics Announces Dosing of First Patient in Phase 1/2a Clinical Trial of BPT567, a First-in-Class Bifunctional PD1-IL18 Immunoconjugate

October 17, 2024
·
3 min read
Press Releases

Eterna Therapeutics and Factor Bioscience Announce Exclusive License and Collaboration Agreement to Accelerate Cell Therapy Development for Oncology, Autoimmune, and Rare Diseases

October 17, 2024
·
4 min read